DOI: 10.2337/db05-1673 © 2006 by the American Diabetes Association CD40–CD40 Ligand Interaction Activates Proinflammatory Pathways in Pancreatic IsletsFrom the Diabetes Research Institute, University of Miami Leonard M. Miller School of Medicine, Miami, Florida Address correspondence and reprint requests to R.L. Pastori, PhD, Diabetes Research Institute, University of Miami Leonard M. Miller School of Medicine, 1450 NW 10th Ave., Miami, FL 33136. E-mail: rpastori{at}med.miami.edu
Abbreviations:
APC, antigen-presenting cell; 7-AAD, 7-aminoactinomycin D; ERK, extracellular signal–regulated kinase; ICAM, intercellular adhesion molecule; I
Pancreatic islet transplantation is becoming an alternative to insulin therapy in patients suffering from brittle type 1 diabetes. A major obstacle to the procedure is the early graft loss caused by nonspecific inflammation at the site of implantation. We recently discovered that CD40, a member of tumor necrosis factor (TNF) receptor family, is expressed in pancreatic ß-cells. CD40 expression in nonhematopoietic cells is generally associated with inflammation. Therefore, we investigated the potential proinflammatory role of CD40 in human and nonhuman primate islets. Islet ß-cells responded to CD40L interaction by secreting interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1, and macrophage inflammatory protein (MIP)-1ß, the latter a chemokine first reported to be produced by islets. Induction of IL-8 and MIP-1ß was confirmed at the transcriptional level by quantitative RT-PCR. MIP-1ß expression in ß-cells was verified by double-immunofluorescence staining. CD40-CD40L interaction activates extracellular signal–regulated kinase 1/2 and nuclear factor-
This article has been cited by other articles:
|
|
|
||||||||||||||||||||||||||||||||||||||